Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05747443 · ClinicalTrials.gov registry record · NA
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
A NA study of Lung Cancer and Lung Cancer Screening, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 1,837
- Enrollment target
- 1
- Study location
NCT05747443 is a NA study of Lung Cancer and Lung Cancer Screening that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 1,837 participants, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (97% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05747443, a NA study of Lung Cancer and Lung Cancer Screening, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,837 participants
- Enrollment target
- 1
- Study location
Study Summary
Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.
Conditions Studied
Interventions
- OTHER Patient Education
- OTHER Stepped Reminders
Study Locations (1)
Washington
- Kaiser Permanente - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,837 participants |
| Start Date | 2022-12-12 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05747443
The ClinicalTrials.gov registry entry for NCT05747443 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,837 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (97% higher). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Patient Education is the first listed.
NCT05747443 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT05747443 about?
NCT05747443 is a clinical study titled "Multilevel Interventions to Increase Adherence to Lung Cancer Screening". Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.
What is the current status of trial NCT05747443?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,837 participants. The study started on 2022-12-12. Estimated completion is 2026-06-30.
What conditions does trial NCT05747443 study?
This clinical trial studies the following conditions: Lung Cancer, Lung Cancer Screening.
What interventions are being tested in trial NCT05747443?
The interventions under investigation include: Patient Education (OTHER), Stepped Reminders (OTHER).
Who is sponsoring clinical trial NCT05747443?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05747443 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.